Stay updated on ASCT With Nivolumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added 'Multiple myeloma' as a related topic and linked 'MedlinePlus Genetics'. The site revision was updated from 3.4.3 to 3.5.0.
    Difference
    0.2%
    Check dated 2026-03-19T06:34:47.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now displays a new revision label: v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T01:21:20.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    A new site revision was added (v3.4.2) and the older entry (v3.4.1) was removed; a government funding notice shown previously is no longer present. No study content, eligibility criteria, or results were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T14:26:32.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    A site-wide notice about government funding status was added and the site revision updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:29:40.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Added a Show glossary feature and updated the site revision to v3.4.0. The label for the last QC update was changed to 'Last Update Submitted that Met QC Criteria' and the 'No FEAR Act data' entry was removed.
    Difference
    0.2%
    Check dated 2026-01-28T06:24:10.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    - Removed related topics: 'Multiple myeloma' and 'MedlinePlus Genetics' from the study page. This may affect searchability and cross-linking to related resources, but does not alter the core trial details.
    Difference
    0.2%
    Check dated 2026-01-21T04:33:15.000Z thumbnail image

Stay in the know with updates to ASCT With Nivolumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.